Khiron Life Sciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

19.01.23	Khiron begins dispensation of insurance-covered prescriptions in Colombia (PR Newswire)
16.01.23	NHS reimburses the cost of cannabis treatment to the first Zerenia™ Clinics UK patient (PR Newswire)
09.01.23	Khiron wins first medical cannabis contract with Colombia's largest public insurance company (PR Newswire)
05.01.23	Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Products (PR Newswire)
30.11.22	Khiron Life Sciences Reports Third Quarter 2022 Financial Results (PR Newswire)
18.11.22	Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022 (PR Newswire)
16.11.22	Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United Kingdom (PR Newswire)
13.09.22	Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital Conference (PR Newswire)
01.09.22	Khiron, the Global Leader in Medical Cannabis Launches New Cannabis Products in Europe including Stellar Genetics from California (PR Newswire)
29.08.22	Khiron Life Sciences Reports Second Quarter 2022 Financial Results (PR Newswire)
22.08.22	Khiron to Host Second Quarter 2022 Conference Call on August 29, 2022 (PR Newswire)
09.08.22	Medical Cannabis Leader Khiron Opens Brazil's First Zerenia™ Clinic (PR Newswire)
03.08.22	Khiron Completes Acquisition of Pharmadrug Production GmbH, Establishing German Pharmaceutical Distribution Capabilities (PR Newswire)
18.07.22	Khiron Appoints Helen Bellwood (ACA) as Interim CFO (PR Newswire)
06.07.22	Medical Cannabis Leader Khiron Continues Global Expansion into Spain (PR Newswire)
28.06.22	Medical Cannabis Innovator Khiron Continues Global Expansion as Industry Leader Throughout Europe and Latin America (PR Newswire)
23.06.22	Khiron Announces Results of 2022 Annual General and Special Meeting (PR Newswire)
31.05.22	Khiron to Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer and Wholesaler, Expanding its European Footprint (PR Newswire)
31.05.22	Khiron Life Sciences Reports First Quarter 2022 Financial Results with Record Revenue in Medical Cannabis (PR Newswire)
25.05.22	Khiron to Host First Quarter 2022 Conference Call on May 31, 2022 (PR Newswire)
10.05.22	Khiron achieves United Kingdom Cannabis Sales Volume Growth of 240% in Q1 2022 (PR Newswire)
02.05.22	Khiron Life Sciences Reports 2021 Fiscal Year End Results (PR Newswire)
27.04.22	Khiron to Host YE and Fourth Quarter 2021 Conference Call on May 2, 2022 (PR Newswire)
11.04.22	Global Medical Cannabis Leader Khiron Opens New Zerenia™ Clinic and Retail Pharmacy in Colombia (PR Newswire)
05.04.22	LEADING GLOBAL MEDICAL CANNABIS COMPANY KHIRON PUBLISHES CLINICAL STUDY ON THE EFFECTIVENESS OF ITS PRODUCTS AT CONTROLLING CHRONIC PAIN (PR Newswire)
30.03.22	Medical Cannabis Innovator Khiron Continues to Disrupt Global Marketplace Signing Partnership with Teleton in Mexico (PR Newswire)
07.03.22	Khiron Life Sciences to Present at Upcoming March Investor Conferences (PR Newswire)
17.02.22	Khiron Adds Another Clinic Location in Peru (PR Newswire)
31.01.22	Khiron Opens New Medical Cannabis Clinic in Colombia (PR Newswire)
04.01.22	Mandatory Insurance Coverage for Medical Cannabis Now Expands to More than 50 million Colombians (PR Newswire)
09.12.21	Khiron to Participate in the Lytham Partners Winter 2021 Investor Conference (PR Newswire)
24.11.21	Khiron Announces Grants of Options and Restricted Share Units (PR Newswire)
22.11.21	Khiron Reports Q3 Results - Revenue Increased 83% YoY, 26% QoQ (PR Newswire)
16.11.21	Khiron to Host Third Quarter 2021 Conference Call on November 22, 2021 (PR Newswire)
08.11.21	Khiron Life Sciences to Present at Upcoming November Investor Conferences (PR Newswire)
03.11.21	Khiron Opens First clinic in Europe with Zerenia™ Clinics UK (PR Newswire)
07.10.21	Khiron presents its first research study with 1,400 patients (PR Newswire)
04.10.21	Khiron Life Sciences to Present at Upcoming October Investor Conferences (PR Newswire)
04.10.21	Khiron reports medical cannabis prescription growth in South America and Europe (PR Newswire)
01.10.21	Khiron's Announces Resignation of Chief Financial Officer Swapan Kakumanu of RTB LLP appointed as Interim CFO (PR Newswire)
13.09.21	Khiron Receives Approval To Renew Its Normal Course Issuer Bid (PR Newswire)
09.09.21	Khiron Announces Intention to Renew its Normal Course Issuer Bid (PR Newswire)
31.08.21	Khiron Registers its First Two Medical Cannabis Products in Peru, Available for Sale Nationwide (PR Newswire)
17.08.21	Khiron veranstaltet Telefonkonferenz zum zweiten Quartal 2021 am 23. August 2021 (PR Newswire)
17.08.21	Khiron to Host Second Quarter 2021 Conference Call on August 23, 2021 (PR Newswire)
17.08.21	Khiron to Host Second Quarter 2021 Conference Call on August 23, 2021 (PR Newswire)
17.08.21	Khiron to Host Second Quarter 2021 Conference Call on August 23, 2021 (PR Newswire)
10.08.21	Khiron Publishes Inaugural 2020 ESG Report, Demonstrating Commitment to Sustainability and Continued Market Leadership (PR Newswire)
10.08.21	Khiron Publishes Inaugural 2020 ESG Report, Demonstrating Commitment to Sustainability and Continued Market Leadership (PR Newswire)
29.07.21	Khiron Welcomes Dr. Eduardo Faveret as Medical Director for Brazil (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Khiron Life Sciences Corp Registered Shs

Aktien Top/Flop

Khiron Life Sciences Peer Group Nachrichten

Meistgelesene Nachrichten